Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	Long-Term Data Support Efficacy, Safety of New Schizophrenia Drug - 8 days ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - 11 months ago
2	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Accepts Biologic License Application for Biosimilar Denosumab - 15 days ago FDA Grants Orphan Drug Designation to ZMA001 for Pulmonary Arterial Hypertension - 4 months ago Novel Drugs Targeting Different Pathways Show Promise in Schizophrenia - 7 months ago AllianceRx Walgreens Pharmacy to Exclusively Provide Vivjoa for Recurrent Vulvovaginal Candidiasis - 8 months ago Prevention, Treatment for Migraine Rapidly Evolves, Calling for Development of Novel Drugs - 12 months ago Datopotamab Deruxtecan Demonstrates Improvement in Progression-Free Survival in HR+, HER2- Breast Cancer - about 1 year ago
3	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about a Merck drug-label controversy, Astellas pulling an application, and more - 18 days ago STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more - 2 months ago STAT+: Pharmalittle: AMA calls for obesity drug coverage; Covid rebound may be more common with Paxlovid than without - about 1 year ago STAT+: Pharmalittle: Wegovy cuts heart attack risk in milestone trial; AstraZeneca prioritizes U.S. for RSV drug amid surge - about 1 year ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - about 1 year ago STAT+: Pharmalittle: FDA panel lacks confidence in Amgen cancer drug data; weight loss drugs linked to rare stomach problems - about 1 year ago
4	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer - 25 days ago Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition - about 1 month ago Neuro Drug Passed Up by Biogen Posts Positive Data for Ionis, Setting Stage for Phase 3 Test - 4 months ago
5	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	More evidence on GLP-1s and opioid addiction - 29 days ago
6	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Long-Term Data Support Non-Hormonal Drug for Hot-Flash Management - 2 months ago Oral Factor XIa Inhibitor Disappoints for Secondary Stroke Prevention - 11 months ago
7	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Centessa reports positive phase 1 clinical data for ORX750 - 2 months ago European Commission grants orphan drug designation for Vivet’s VTX-806 - 2 months ago Kanabo and City Dock Pharmacy team up - 10 months ago
8	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	MHRA approves Astellas’ Vyloy combination for gastric cancer - 3 months ago
9	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Pharmalittle: We’re reading about a negative U.K. review of Leqembi, Bavarian Nordic’s strong earnings, and more - 3 months ago
10	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Axatilimab-csfr for cGVHD - 3 months ago

Journalists covering ganaxolone